Pharmacotherapy of Glaucoma
نویسندگان
چکیده
منابع مشابه
Recent advances in pharmacotherapy of glaucoma
Glaucoma is a slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve axons, leading to irreversible blindness if left undiagnosed and untreated. Although increased intraocular pressure is a major risk factor of glaucoma, other factors include increased glutamate levels, alterations in nitric oxide (NO) metabolism, vascular alterations and oxidative damage caused ...
متن کاملPatient persistency with pharmacotherapy in the management of glaucoma.
PURPOSE To evaluate persistency with monotherapy in the treatment of glaucoma in patients new to pharmacological management. METHODS This population-based, retrospective cohort study, using managed care administrative claims data, included patients who were 20 years of age and older and who initiated monotherapy with betaxolol, brimonidine, dorzolamide, latanoprost, or timolol between May 199...
متن کاملFactors associated with adherence to glaucoma pharmacotherapy in the primary care setting
BACKGROUND Primary open-angle glaucoma is a leading cause of irreversible blindness. OBJECTIVES To identify factors associated with adherence to glaucoma pharmacotherapy in the primary care setting, focusing on physicians' role. METHODS Patients were recruited from primary care clinics and telephone-interviewed using a structured questionnaire that addressed patient-, medication-, environme...
متن کاملWhat is the Real Cause of Glaucoma?
Introduction: The term glaucoma refers to a group of diseases that have a characteristic optic neuropathy with associated visual field loss in common. Intraocular pressure has been considered to be the only causal factor for glaucoma and the only factor that can be manipulated to alter the course of the disease. But considering high intraocular pressure as the only factor responsible for glauco...
متن کاملA Review of Pharmacotherapy for Coronavirus Disease 2019 (COVID-19)
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high prevalence of this disease and the high number of people at risk, medical staff needs accurate evidence regarding effective drug treatments for this infection. There is currently no effective treatment for COVID-19. B...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Ocular Pharmacology and Therapeutics
سال: 2015
ISSN: 1080-7683,1557-7732
DOI: 10.1089/jop.2014.0067